Genetic polymorphisms of MPO, COMT, MnSOD, NQO1, interactions with environmental exposures and bladder cancer risk

被引:166
作者
Hung, RJ
Boffetta, P [1 ]
Brennan, P
Malaveille, C
Gelatti, U
Placidi, D
Carta, A
Hautefeuille, A
Porru, S
机构
[1] Intl Agcy Res Canc, F-69008 Lyon, France
[2] Univ Brescia, Inst Hyg, I-25125 Brescia, Italy
[3] Univ Brescia, Inst Occupat Hlth, I-25125 Brescia, Italy
[4] Univ Calif Los Angeles, Dept Epidemiol, Los Angeles, CA 90095 USA
关键词
D O I
10.1093/carcin/bgh080
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Tobacco smoking and occupational exposure are major risk factors of bladder cancer via exposure to polycyclic aromatic hydrocarbons (PAHs) and aromatic amines, which lead to oxidative stress and DNA damage. Several enzymes, which play key roles in oxidative stress are polymorphic in humans. Myeloperoxidase (MPO) produces a strong oxidant for microbicidal activity, and activates carcinogens in tobacco smoke. Catechol-O-methyltransferase (COMT) catalyzes the methylation of endo- and xenobiotics and prevents redox cycling. NAD(P)H:quinone oxidoreductase (NQO1) catalyzes the two-electron reduction of quinoid compounds, which also protects cells from redox cycling. Manganese superoxide dismutase (MnSOD) protects cells from free radical injury. To test the hypothesis that the risk of bladder cancer can be influenced by polymorphisms in the genes that modulate oxidative stress, in particular by interacting with environmental carcinogens, we conducted a hospital-based case-control study among men in Brescia, Northern Italy. We recruited and interviewed 201 incident cases and 214 controls from 1997 to 2000. Occupational exposures to PAHs and aromatic amines were coded blindly by occupational physicians. Unconditional multivariate logistic regression was applied to model the association between genetic polymorphisms and bladder cancer risk and the effect of modifications of smoking and occupational exposures were evaluated. MPO G-463A homozygous variant was associated with a reduced risk of bladder cancer with an OR of 0.31 (95% CI = 0.12-0.80). MnSOD Val/Val genotype increased the risk of bladder cancer with OR of 1.91 (95% CI = 1.20-3.04), and there was a combined effect with smoking (OR = 7.20, 95% CI = 3.23-16.1) and PAH (OR = 3.02, 95% CI = 1.35-6.74). We did not observe an effect of COMT Val108Met polymorphism. These findings suggest that individual susceptibility of bladder cancer may be modulated by MPO and MnSOD polymorphisms, and that the combination of genetic factors involved in oxidative stress response with environmental carcinogens may play an important role in bladder carcinogenesis.
引用
收藏
页码:973 / 978
页数:6
相关论文
共 48 条
  • [1] Ambrosone CB, 1999, CANCER RES, V59, P602
  • [2] Genetic polymorphism of N-acetyltransferases, glutathione S-transferase M1 and NAD(P)H:quinone oxidoreductase in relation to malignant and benign pancreatic disease risk
    Bartsch, H
    Malaveille, C
    Lowenfels, AB
    Maisonneuve, P
    Hautefeuille, A
    Boyle, P
    [J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 1998, 7 (03) : 215 - 223
  • [3] Myeloperoxidase (MPO) genotype and lung cancer histologic types:: The MPO-463 A allele is associated with reduced risk for small cell lung cancer in smokers
    Dally, H
    Gassner, K
    Jäger, B
    Schmezer, P
    Spiegelhalder, B
    Edler, L
    Drings, P
    Dienemann, H
    Schulz, V
    Kayser, K
    Bartsch, H
    Risch, A
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2002, 102 (05) : 530 - 535
  • [4] Free radicals in the physiological control of cell function
    Dröge, W
    [J]. PHYSIOLOGICAL REVIEWS, 2002, 82 (01) : 47 - 95
  • [5] Garner EIO, 2002, CANCER RES, V62, P3058
  • [6] GERIN M, 1985, J OCCUP ENVIRON MED, V27, P420
  • [7] Goodman JE, 2000, CANCER EPIDEM BIOMAR, V9, P1373
  • [8] COMT genotype, micronutrients in the folate metabolic pathway and breast cancer risk
    Goodman, JE
    Lavigne, JA
    Wu, K
    Helzlsouer, KJ
    Strickland, PT
    Selhub, J
    Yager, JD
    [J]. CARCINOGENESIS, 2001, 22 (10) : 1661 - 1665
  • [9] Hamajima Nobuyuki, 2002, Int J Clin Oncol, V7, P103
  • [10] No association between Parkinson's disease and low-activity alleles of catechol O-methyltransferase
    Hoda, F
    Nicholl, D
    Bennett, P
    Arranz, M
    Aitchison, KJ
    AlChalabi, A
    Kunugi, H
    Vallada, H
    Leigh, PN
    Chaudhuri, KR
    Collier, DA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 228 (03) : 780 - 784